Takeda Pharmaceutical Company Limited Share Price
Stocks
4502
JP3463000004
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,513.00 JPY | -3.59% |
|
-2.39% | +14.02% |
| 07-30 | Keros Therapeutics to Receive $20 Million Development Milestone Payment From Takeda | DJ |
| 07-30 | Takeda Pharmaceutical Company Limited, Q1 2027 Earnings Call, Jul 30, 2026 |
| Market Cap | 8,803B 55.24B 48.02B 44.7B 41.04B 77.49B 5,273B 78.7B 527B 207B 2,625B 207B 203B | P/E 2027 * |
44.3x | P/E 2028 * | 27.4x |
|---|---|---|---|---|---|
| Enterprise Value | 12,737B 79.92B 69.48B 64.67B 59.37B 112B 7,630B 114B 762B 299B 3,798B 300B 294B | EV / Sales 2027 * |
2.73x | EV / Sales 2028 * | 2.66x |
| Free-Float |
99.28% | Yield 2027 * |
3.71% | Yield 2028 * | 3.8% |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | -3.59% | ||
| 1 week | -2.39% | ||
| 1 month | +6.94% | ||
| 3 months | +4.61% | ||
| 6 months | +5.17% | ||
| Current year | +14.02% |
| 1 week | 5,438 |  | 5,903 |
| 1 month | 5,190 | | 5,903 |
| Current year | 4,710 | | 6,033 |
| 1 year | 4,102 | | 6,033 |
| 3 years | 3,852 | | 6,033 |
| 5 years | 2,993 | | 6,033 |
| 10 years | 2,894.5 | | 6,693 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 23/06/2026 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 31/03/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 31/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 31/05/2015 |
Steven Gillis
BRD | Director/Board Member | 73 | 31/12/2018 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 31/05/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/07/26 | Issuer sale | Director | -1,152 | 0.0001% | ||
| 10/07/26 | Issuer sale | President, Japan Pharma B.U. | -1,022 | 0.0001% | ||
| 10/07/26 | Issuer sale | Director | -1,152 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.59% | -2.39% | +31.26% | +27.00% | 55.24B | |
| -0.53% | -3.95% | +55.23% | +152.74% | 1,024B | |
| +0.21% | -2.68% | +55.61% | +53.02% | 618B | |
| -2.51% | -3.25% | +32.76% | +67.76% | 443B | |
| +0.06% | -0.42% | +37.53% | +30.67% | 349B | |
| -0.14% | -0.24% | +34.41% | +39.01% | 297B | |
| -0.69% | -0.30% | +11.55% | +12.93% | 264B | |
| -7.37% | -4.40% | -2.54% | -43.87% | 209B | |
| -0.64% | +2.43% | +30.52% | +64.49% | 208B | |
| -0.82% | +0.70% | +15.96% | +71.01% | 162B | |
| Average | -1.60% | -1.32% | +30.23% | +47.48% | 362.9B | |
| Weighted average by Cap. | -1.03% | -1.94% | +39.12% | +72.26% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,662B 29.26B 25.43B 23.67B 21.73B 41.04B 2,793B 41.68B 279B 110B 1,390B 110B 107B | 4,740B 29.74B 25.85B 24.06B 22.09B 41.72B 2,839B 42.37B 284B 111B 1,413B 112B 109B |
| Net income | 186B 1.17B 1.01B 943M 866M 1.64B 111B 1.66B 11.12B 4.36B 55.41B 4.38B 4.28B | 313B 1.97B 1.71B 1.59B 1.46B 2.76B 188B 2.8B 18.75B 7.36B 93.44B 7.38B 7.22B |
| Net Debt | 3,934B 24.68B 21.46B 19.97B 18.34B 34.63B 2,356B 35.17B 235B 92.4B 1,173B 92.7B 90.67B | 3,784B 23.75B 20.64B 19.21B 17.64B 33.31B 2,267B 33.83B 226B 88.88B 1,128B 89.18B 87.22B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | JP¥5,513.00 | -3.59% | 7,218,600 |
| 30/07/26 | JP¥5,718.00 | -2.21% | 4,859,800 |
| 29/07/26 | JP¥5,847.00 | +1.79% | 5,289,600 |
| 28/07/26 | JP¥5,744.00 | -0.43% | 3,918,100 |
| 27/07/26 | JP¥5,769.00 | +2.14% | 4,647,600 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
Select your edition
All financial news and data tailored to specific country editions
